
DoseOptics Receives FDA 510(k) Clearance for BeamSite™
DoseOptics LLC announced today that it has received 510(k) clearance for BeamSite™ by the US Food and Drug Administration.Radiation therapy is a powerful tool used by oncologists to provide curative treatments to over a million patients per year in the…